Thomas Hach | Executive Director, Patient Engagement Cardiovascular, Renal & Metabolism
Novartis

Thomas Hach, Executive Director, Patient Engagement Cardiovascular, Renal & Metabolism, Novartis

Thomas Hach, MD, is Executive Director Patient Engagement for Cardiovascular, Renal & Metabolism (CRM) at Novartis. He is leading end-to-end patient engagement strategy and operations for the broad CRM portfolio at Novartis. Thomas also held positions of Global Brand Medical Director Neuroscience, Senior Global Health Advisor and Director Healthcare Systems. His passion and expertise are in precision medicine, patient centricity and partnerships. He joined Novartis from Boehringer Ingelheim, where he was Global Senior Medical Director, Therapeutic Area Metabolism. Prior to that, he was an associate principal at McKinsey & Company, serving as a leader in the pharmaceuticals and healthcare practice. Dr. Hach conducted several years of research and clinical practice in diabetes/microcirculation at Karolinska Institutet, Sweden. At the beginning of his clinical career he worked in orthopedic surgery in Sweden and Germany. He received his medical degree from University of Mainz, Germany.

Appearances:



BioData World Congress Day 2 @ 14:00

Patient Organisations and Industry Collaborations for Data Curation

BioData World Congress Day 3 @ 10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
last published: 21/Sep/21 15:25 GMT
last published: 21/Sep/21 15:25 GMT

back to speakers

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034